Howe & Rusling Inc. Has $407,000 Holdings in Transcat, Inc. (NASDAQ:TRNS)

Howe & Rusling Inc. decreased its holdings in Transcat, Inc. (NASDAQ:TRNS) by 43.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,851 shares of the scientific and technical instruments company’s stock after selling 3,003 shares during the period. Howe & Rusling Inc.’s holdings in Transcat were worth $407,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. JPMorgan Chase & Co. raised its stake in Transcat by 153.1% in the 4th quarter. JPMorgan Chase & Co. now owns 26,434 shares of the scientific and technical instruments company’s stock valued at $2,795,000 after acquiring an additional 15,991 shares during the period. KLP Kapitalforvaltning AS acquired a new position in shares of Transcat in the fourth quarter valued at $190,000. Diamond Hill Capital Management Inc. raised its position in shares of Transcat by 11.7% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 6,143 shares of the scientific and technical instruments company’s stock valued at $650,000 after purchasing an additional 643 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Transcat during the 4th quarter worth about $2,071,000. Finally, Victory Capital Management Inc. boosted its holdings in shares of Transcat by 1.4% during the 4th quarter. Victory Capital Management Inc. now owns 34,710 shares of the scientific and technical instruments company’s stock worth $3,670,000 after buying an additional 480 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Craig D. Cairns acquired 1,200 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The stock was acquired at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the acquisition, the director now directly owns 1,910 shares of the company’s stock, valued at approximately $147,108.20. This trade represents a 169.01 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 2.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. HC Wainwright lowered their target price on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Northland Securities reiterated a “market perform” rating and set a $85.00 price objective (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Craig Hallum raised their price target on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Finally, Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Transcat has an average rating of “Hold” and an average target price of $111.50.

Transcat Trading Up 1.5 %

Shares of TRNS stock opened at $72.93 on Friday. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $678.91 million, a P/E ratio of 39.42 and a beta of 0.66. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12. The stock’s fifty day simple moving average is $80.38 and its 200 day simple moving average is $101.33.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the previous year, the company earned $0.56 EPS. As a group, sell-side analysts predict that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.